You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 244 No. 12, September 19, 1980 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibiotic Activity in Surgical Incisions

The Basis for Prophylaxis in Selected Operations

Hiram C. Polk, Jr, MD; Laura Trachtenberg, MA; Michael P. Finn, MD

JAMA. 1980;244(12):1353-1354.


Abstract

Perioperative antibiotic administration to produce systemic effects reduces the frequency of operative wound infection in selected procedures. Controlled clinical trials now indicate that cephalothin sodium may not be effective in this role, whereas cephaloridine and cefazolin sodium have been beneficial. Review of estimates of incisional antibiotic concentrations taken during prospective patient studies display patterns compatible with these data. Each drug reaches acceptable incisional concentrations, which are relatively well maintained for cephaloridine and cefazolin; cephalothin disappears from human incisions so rapidly as to provide little wound protection in operations lasting more than one hour.

(JAMA 244:1353-1354, 1980)



Author Affiliations

From the Department of Surgery and the Price Institute of Surgical Research, University of Louisville School of Medicine, Health Sciences Center, Louisville.


Footnotes

Reprint requests to Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40292 (Dr Polk).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ensuring Appropriate Timing of Antimicrobial Prophylaxis
Rosenberg et al.
JBJS 2008;90:226-232.
ABSTRACT | FULL TEXT  

Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients
Bond and Raehl
Am J Health Syst Pharm 2007;64:1935-1942.
ABSTRACT | FULL TEXT  

Renewal of Surgical Quality and Safety Initiatives: A Multispecialty Challenge
Polk
Mayo Clin Proc. 2006;81:345-352.
ABSTRACT | FULL TEXT  

Exploring obstacles to proper timing of prophylactic antibiotics for surgical site infections
Tan et al.
Qual Saf Health Care 2006;15:32-38.
ABSTRACT | FULL TEXT  

Use of Antimicrobial Prophylaxis for Major Surgery: Baseline Results From the National Surgical Infection Prevention Project
Bratzler et al.
Arch Surg 2005;140:174-182.
ABSTRACT | FULL TEXT  

Does Intraoperative Blood Loss Affect Antibiotic Serum and Tissue Concentrations?
Swoboda et al.
Arch Surg 1996;131:1165-1172.
ABSTRACT  

Interferon Gamma and Tumor Necrosis Factor Alpha: Use in Gram-negative Infection After Shock
Malangoni et al.
Arch Surg 1990;125:444-446.
ABSTRACT  

Intraoperative Serum and Tissue Activity of Cefazolin and Cefoxitin
DiPiro et al.
Arch Surg 1985;120:829-832.
ABSTRACT  

A Remotely Programmable Insulin Delivery System: Successful Short-term Implantation in Man
Schade et al.
JAMA 1982;247:1848-1853.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.